Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anshul Specialty Molecules is a prominent Indian manufacturer specializing in the production of high-quality specialty chemicals, pharmaceutical intermediates, and fine chemicals. Founded in 1978, the company serves a global clientele across the pharmaceutical, agrochemical, and performance chemical sectors. With state-of-the-art manufacturing facilities located in Roha and Mahad, they offer custom synthesis and contract development and manufacturing (CDMO) services supported by robust R&D capabilities. Their expertise lies in complex chemical reactions, including high-pressure hydrogenation and halogenation, ensuring stringent quality standards for the life sciences industry. The company is a key player in the supply chain for active pharmaceutical ingredients (APIs), providing critical building blocks to international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anshul Specialty Molecules.